WebContact Information Website www.myneo.me Ownership Status Privately Held (backing) Financing Status Accelerator/Incubator Backed Primary Industry Biotechnology Other Industries Discovery Tools (Healthcare) Primary Office MeetDistrict 540, Ottergemsesteenweg Zuid 808 Bus B511 9000 Ghent Belgium Want detailed data on 3M+ … Web27 vacatures voor Clinical Research in 9040 Gent op Indeed.com. Solliciteer op vacatures voor Clinical Assistant, Supply Manager, Junior Bioinformatician en ander werk.
Neoantigen-directed therapeutics in the clinic: where are we?
WebMay 25, 2024 · Issuer: CureVac / Key word(s): Alliance25.05.2024 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development CureVac is broadening its foundation in oncology, leveraging recent progress with its second … WebMay 25, 2024 · myNEO is a Belgian biotech company that focuses on the development of immunotherapies finetuned against the tumour of cancer patients. The core technology to its clinical development is an advanced data analysis platform that allows to rapidly screen immuno-genomic datasets from enrolled patients and their tumours. suzuki 6hp 4 stroke outboard price
myNEO - Overview, News & Competitors ZoomInfo.com
WebYour multidisciplinary care team – which includes radiation oncologists, radiation oncology nurses, radiation therapists, medical physicists and medical dosimetrists, among other … WebApr 7, 2024 · While OncoDNA will perform whole genome and whole transcriptome sequencing, myNEO will handle the advanced interpretation of the sequenced data and design the optimal vaccine construct for maximum clinical benefit. The project promises to guide patients through a completely personalized journey. WebmyNEO 2,041 من المتابعين على LinkedIn. Unlock the potential of neoantigen immunotherapies with data-driven innovation myNEO leads in Personalised Medicine and genomic-informed drug discovery in the key therapeutic areas of oncology and immunology. The myNEO ImmunoEngine© is a sequencing-based computational neoepitope selection platform that … bari morta sabrina